MYLA COLLINS: Open Payments
NPI 1720837578 · STOCKBRIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 53 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,083 · 2025 $1,208
Food & beverage: $1,208
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $248 |
| Lilly USA, LLC | 7 | $132 |
| Xeris Pharmaceuticals, Inc. | 5 | $109 |
| CeQur Corporation | 1 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Amneal Pharmaceuticals LLC | 4 | $61 |
| Madrigal Pharmaceuticals | 2 | $54 |
| Abbott Laboratories | 3 | $53 |
| Verity Pharmaceuticals Inc. | 2 | $47 |
| SANOFI-AVENTIS U.S. LLC | 2 | $45 |
Products named: Wegovy, CeQur Simplicity, RECORLEV, LEQVIO, UNITHROID, MOUNJARO, Rybelsus, REZDIFFRA.
Industry payments across GA — which companies pay providers there.
